Suppr超能文献

非心脏手术前的心脏筛查。

Cardiac screening before noncardiac surgery.

作者信息

Williams Freddie M, Bergin James D

机构信息

Cardiovascular Medicine, University of Virginia Health System, 1215 Lee Street, Box 800158, Charlottesville, VA 22908, USA.

出版信息

Surg Clin North Am. 2009 Aug;89(4):747-62, vii. doi: 10.1016/j.suc.2009.05.001.

Abstract

Cardiovascular complications are infrequent but can result in significant morbidity following noncardiac surgery, especially in patients with peripheral vascular disease or increased age. All patients require some level of preoperative screening to identify and minimize immediate and future risk, with a careful focus on known coronary artery disease or risks for coronary artery disease and functional capacity. The 2007 American College of Cardiology/American Heart Association Guidelines are clear that noninvasive and invasive testing should be limited to circumstances in which results will clearly affect patient management or in which testing would otherwise be indicated. beta-Blocker therapy has become controversial in light of recent publications but should be continued in patients already on therapy, and started in patients with high cardiac risk undergoing intermediate- or high-risk surgery.

摘要

心血管并发症并不常见,但在非心脏手术后可能导致严重的发病情况,尤其是在患有外周血管疾病或年龄较大的患者中。所有患者都需要一定程度的术前筛查,以识别并尽量降低近期和远期风险,重点要仔细关注已知的冠状动脉疾病或冠状动脉疾病风险以及功能能力。2007年美国心脏病学会/美国心脏协会指南明确指出,非侵入性和侵入性检查应限于检查结果将明显影响患者管理的情况,或在其他情况下有检查指征的情况。鉴于最近的出版物,β受体阻滞剂治疗已成为有争议的话题,但对于已经在接受治疗的患者应继续使用,对于接受中、高风险手术且心脏风险高的患者应开始使用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验